Mentor’s Stock Jumps In Q3 On Silicone Implant “Approvable” Letter

FDA's "approvable" letter to Mentor for the Memory Gel silicone breast implants drove the firm's stock up 32.6% to $55.01 for the quarter, but investor tunnel-vision could keep future stock movement tied to FDA's final decision